Switching from IV to subcutaneous infliximab maintenance therapy is associated with high treatment persistence and a stable ...
Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback